• Je něco špatně v tomto záznamu ?

May circulating steroids reveal a predisposition to intrahepatic cholestasis of pregnancy in non-pregnant women

P. Šimják, M. Hill, A. Pařízek, L. Vítek, M. Velíková, M. Dušková, R. Kancheva, J. Bulant, M. Koucký, Z. Kokrdová, K. Adamcová, A. Černý, Z. Hájek, L. Stárka

. 2018 ; 67 (Suppl. 3) : S499-S510.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19005356

Intrahepatic cholestasis of pregnancy (ICP) is a frequent liver disorder, mostly occurring in the third trimester. ICP is not harmful to the mothers but threatens the fetus. The authors evaluated steroid alterations in maternal and mixed umbilical blood to elucidate their role in the ICP development. Ten women with ICP were included in the study. Steroids in the maternal blood were measured by Gas Chromatography-Mass Spectrometry (GC-MS) (n=58) and RIA (n=5) at the diagnosis of ICP, labor, day 5 postpartum, week 3 postpartum and week 6 postpartum. The results were evaluated by ANOVA consisting of the subject factor, between subject factors ICP, gestational age at the diagnosis of ICP and gestational age at labor, within-subject factor Stage and ICP × Stage interaction. The 17 controls were firstly examined in the week 36 of gestation. ICP patients showed reduced CYP17A1 activity in the C17,20 lyase step thus shifting the balance between the toxic conjugated pregnanediols and harmless sulfated 5alpha/beta-reduced-17-oxo C19 steroids. Hence, more toxic metabolites originating in maternal liver from the placental pregnanes may penetrate backward to the fetal circulation. As these alterations persist in puerperium, the circulating steroids could be potentially used for predicting the predisposition to ICP even before next pregnancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19005356
003      
CZ-PrNML
005      
20210602141457.0
007      
ta
008      
190204s2018 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934028 $2 doi
035    __
$a (PubMed)30484676
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šimják, Patrik $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic $7 xx0221733
245    10
$a May circulating steroids reveal a predisposition to intrahepatic cholestasis of pregnancy in non-pregnant women / $c P. Šimják, M. Hill, A. Pařízek, L. Vítek, M. Velíková, M. Dušková, R. Kancheva, J. Bulant, M. Koucký, Z. Kokrdová, K. Adamcová, A. Černý, Z. Hájek, L. Stárka
520    9_
$a Intrahepatic cholestasis of pregnancy (ICP) is a frequent liver disorder, mostly occurring in the third trimester. ICP is not harmful to the mothers but threatens the fetus. The authors evaluated steroid alterations in maternal and mixed umbilical blood to elucidate their role in the ICP development. Ten women with ICP were included in the study. Steroids in the maternal blood were measured by Gas Chromatography-Mass Spectrometry (GC-MS) (n=58) and RIA (n=5) at the diagnosis of ICP, labor, day 5 postpartum, week 3 postpartum and week 6 postpartum. The results were evaluated by ANOVA consisting of the subject factor, between subject factors ICP, gestational age at the diagnosis of ICP and gestational age at labor, within-subject factor Stage and ICP × Stage interaction. The 17 controls were firstly examined in the week 36 of gestation. ICP patients showed reduced CYP17A1 activity in the C17,20 lyase step thus shifting the balance between the toxic conjugated pregnanediols and harmless sulfated 5alpha/beta-reduced-17-oxo C19 steroids. Hence, more toxic metabolites originating in maternal liver from the placental pregnanes may penetrate backward to the fetal circulation. As these alterations persist in puerperium, the circulating steroids could be potentially used for predicting the predisposition to ICP even before next pregnancy.
650    _2
$a dospělí $7 D000328
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a intrahepatální cholestáza $x krev $x diagnóza $x genetika $7 D002780
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $x genetika $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a jaterní testy $x trendy $7 D008111
650    _2
$a placentární oběh $x fyziologie $7 D021041
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x krev $x diagnóza $x genetika $7 D011248
650    _2
$a steroidy $x krev $7 D013256
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hill, Martin, $d 1962- $7 mzk2005304431 $u Institute of Endocrinology, Prague, CzechRepublic
700    1_
$a Pařízek, Antonín, $d 1959- $7 mzk2005294935 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Vítek, Libor, $d 1969- $7 xx0035071 $u Institute of Medical Biochemistry and Laboratory Diagnostics and Fourth Department ofInternal Medicine, General University Hospital and First Faculty of Medicine of Charles Universityin Prague, Czech Republic
700    1_
$a Velíková, Marta $7 xx0209755 $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Dušková, Michaela $7 xx0080454 $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Kantcheva, Radmila $7 xx0102173 $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Bulant, Josef $7 xx0207735 $u Institute of Endocrinology, Prague, Czech Republic; Department of Pediatrics and Adolescent Medicine, General UniversityHospital and First Faculty of Medicine of Charles University in Prague, Czech Republic
700    1_
$a Koucký, Michal $7 xx0107050 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Kokrdová, Zuzana $7 xx0108022 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Adamcová, Karolína $7 xx0222599 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Černý, Andrej $7 xx0232894 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Hájek, Zdeněk, $d 1943- $7 skuk0000531 $u Department of Gynecology and Obstetrics, General University Hospital and First Faculty ofMedicine, Charles University in Prague, Czech Republic
700    1_
$a Stárka, Luboslav, $d 1930- $7 jn19990209795 $u Institute of Endocrinology, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 3 (2018), s. S499-S510
773    0_
$t Dr. Karel Šilink - The 110th anniversary of the birth $g (2018), s. S499-S510 $w MED00206981
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30484676 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190204 $b ABA008
991    __
$a 20210602141455 $b ABA008
999    __
$a ok $b bmc $g 1377929 $s 1043561
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c Suppl. 3 $d S499-S510 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2018 $d S499-S510 $m Dr. Karel Šilink - The 110th anniversary of the birth $x MED00206981
LZP    __
$b NLK118 $a Pubmed-20190204

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...